Interestingly, in the gastric cancer cells with nicotine-induced COX-2-derived PGE2 release and cell proliferation, the COX-2 inhibitor SC-236 caused G1 arrest and abrogated nicotine-induced cell proliferation [13]. Here, PTGS2 is linked to gastric cancer.